SEC Form 4 · accession 0001104659-26-083516
Armata Pharmaceuticals, Inc. · ARMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deborah Birx
Officer — Chief Executive Officer · Director
Period of report
Jul 10, 2026
Accepted (ET)
Jul 14, 2026 · 4:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000921114
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 10, 2026 | F | 14,041 | $4.26 | D | 198,417 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units.